UBT251
UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)
The United Bio-Technology (Hengqin) Co · Phase 3 · Active, not recruiting · Enrollment 600
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.